Search
Menu
Recombinant Antibodies for Reliable In Vivo Research
RecombiMAb™ recombinant antibodies from Bio X Cell are sequence verified and optimized for lot-to-lot consistency. These engineered antibodies provide a species-matching low immunogenicity option for reliable in vivo results with reduced complications. These antibodies retain the same epitope specificity as their hybridoma-derived counterparts by cloning the antibody-coding genes into high-yield expression systems and expressing them in mammalian cells.
RecombiMAb™ antibodies are produced with either mouse or human constant regions to reduce immune response in mouse, humanized mouse, and in vitro human organoid and organ-on-chip models. Each lot undergoes stringent validation for antigen binding, pathogen screening, protein aggregation, and endotoxin levels (as low as ≤0.5 EU/mg), ensuring exceptional performance.
Select RecombiMAb™ products are available with Fc silencing mutations (e.g., D265A, LALA-PG) for studies requiring the elimination of Fc-mediated effector functions. Lot-specific Certificates of Analysis (CoAs) are readily available for every product and can be easily shared with veterinarians, lab managers, and vivarium teams, ensuring transparency, compliance, and confidence in every experiment.
Need more than off-the-shelf antibodies? Bio X Cell Antibody Production Services provide flexible solutions from hybridoma and mammalian expression to custom recombinant engineering, gram-scale manufacturing, and advanced conjugation to power your next breakthrough discovery. See all custom service capabilities.
Do you have questions? Visit our FAQs page, contact us by email customerservice@bioxcell.com or call +1-866-787-3444.
View More
Explore Our Antibody Solutions
Discover the difference between antibody lines, customization options, and quality testing.
Access Product Guide